HealthDeveloping
Hepatitis B vaccine trial in Guinea-Bissau will not go ahead, lead researcher says
By Mantle News
Coverage spectrum
Covered by 3 outlets, mostly left-leaning (67%).
4 articles in total. The spectrum counts each outlet once and leaves opinion out. How we measure bias

A hepatitis B vaccine trial in newborns in Guinea-Bissau will not go ahead, according to Frederik Schaltz-Buchholzer, a Danish researcher on the study, who said on LinkedIn that the necessary government approval was not given. Guinea-Bissau’s health minister, Quinhin Nantote, had earlier denied that the project would move forward. Police searched the offices of the Bandim Health Project on Monday and seized hepatitis B vaccine doses, officials said on Facebook. Reports say the study was to be funded with $1.6 million from the US Centers for Disease Control and Prevention, matched by private foundations. Critics, including World Health Organization officials, had raised ethical concerns about the trial.
Headline and summary written by Mantle’s AI from the coverage below, under published rules. How this works
What happened
Key points
Each point shows who reports it, from Far Left to Far Right.
The lead researcher said on LinkedIn that the trial will not move forward in Guinea-Bissau because the necessary governmental approval was not given.
Reported byFar Left1Left1Far Right1See the outletsHide the outlets
- Far Left
- Rolling Stone
- Left
- The Guardian
- Far Right
- The Epoch Times
Police searched the offices of the Bandim Health Project on Monday and seized hepatitis B vaccine doses, officials said on Facebook.
One outletThe Guardian· Left
Officials said the seizure did not point to irregularities in the quality, safety or effectiveness of the vaccines.
One outletThe Guardian· Left
The study was to be funded with $1.6 million from the US Centers for Disease Control and Prevention, matched by private foundations.
One side only: the leftReported byFar Left1Left1See the outletsHide the outlets
- Far Left
- Rolling Stone
- Left
- The Guardian
Health minister Quinhin Nantote had earlier denied that the project would move forward.
One outletThe Guardian· Left
Critics, including World Health Organization officials, raised ethical concerns about the trial.
Reported byFar Left1Far Right1See the outletsHide the outlets
- Far Left
- Rolling Stone
- Far Right
- The Epoch Times
What is contested
Where accounts differ
Points the coverage does not agree on, and who says what.
Whether the hepatitis B vaccine trial will move forward in Guinea-Bissau.
Health minister Quinhin Nantote previously denied that the project would move forward. The lead researcher wrote that the trial ‘will not move forward’ because the necessary governmental approval was not given.
How each side tells it
Compare views
Every side present reports the Guinea-Bissau hepatitis B vaccine trial will not go ahead after its lead researcher said it lacked government approval. Left coverage stresses backlash and ethics concerns, while the right-side report centers the researcher’s view that the trial would have challenged medical assumptions.
the left
2 outlets
Left headlines center the controversy and the backlash, with the Guardian naming Robert F Kennedy Jr. and Rolling Stone, the Far Left outlet, saying the study is axed.
Controversial US-backed vaccine trial in African newborns halted
The GuardianLeftAll left-leaning headlines the center
No coverage yet
No center outlet that Mantle follows has covered this story yet. That absence is part of the picture.
the right
1 outlet
The one right-side report, from a Far Right outlet, puts the researcher’s own account in the headline and describes the trial as one that would have challenged medical assumptions.
US-Backed Hepatitis B Vaccine Trial Won’t Be Happening, Researcher Says
The Epoch TimesFar RightAll right-leaning headlines
The words they chose
Language to notice
Words that carry a judgement beyond the facts. Tap a highlighted word anywhere on the page to see why.
Left1
Is Axed
Center
Has not covered this story.
Right0
No loaded words in its own voice.
In the outlets’ own words
Loaded verb
Is AxedMore neutral: will not proceed
Axed is informal and implies the trial was cut off by a decision, where the source only says it will not proceed.
Is Axed After Widespread Backlash
Used byRolling Stone (Far Left)
See for yourself
Side by side
What each side leads with and what it leaves out. Open a side to read its headlines.
From the left
2 outletsLeads with
- backlash and ethical objections
- police raid and seizure of vaccine doses
- links to Robert F Kennedy Jr.
See the 2 headlines from the leftHide the headlines
- Rolling StoneFar Left
A Controversial Hepatitis B Vaccine Study Championed by RFK Jr. Loaded verb“Is Axed”Axed is informal and implies the trial was cut off by a decision, where the source only says it will not proceed.More neutral: will not proceedDisagree with this highlight? After Widespread Backlash
After months of reporting by Rolling Stone, a trial declared ‘unethical’ by WHO will not move forward
- The GuardianLeft
Controversial US-backed vaccine trial in African newborns halted
Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. …
1 more from The Guardian
From the center
0 outletsNo center outlet that Mantle follows has covered this story yet. That absence is part of the picture.
From the right
1 outletLeads with
- the researcher’s account of the halt
- the trial’s aim to challenge medical assumptions
- the number of infants and mothers involved
Leaves out
- police seizure of vaccine doses
Reported by other sides, not found in this side’s coverage.
See the headline from the rightHide the headlines
- The Epoch TimesFar Right
US-Backed Hepatitis B Vaccine Trial Won’t Be Happening, Researcher Says
The trial would have ‘challenged prevailing medical assumptions,’ according to the researcher.
Articles you open from here build My Mix, a private picture of how your reading spreads across the spectrum, kept on this device. What is My Mix?
The left is Far Left and Left together. The right is Right and Far Right together. Every outlet keeps its own five-point rating.
Who reported it when
How the coverage built up
Left
First to report
The Guardian, Oct 20, 3:18 PM EDT
Center
No report yet
From the outlets Mantle follows
Right
1 day 1 hr later
Its first report, Oct 21, 4:48 PM EDT
See the order the outlets reported inHide the order
- The GuardianLeftOct 20, 3:18 PM EDT
- The Epoch TimesFar RightOct 21, 4:48 PM EDT
- Rolling StoneFar LeftOct 22, 10:38 AM EDT
Times are the ones the outlets published in their own feeds, in Eastern time. Opinion is left out.
Read next
More on Health
Crime & JusticeBreaking
Justice Dept. charges 15 over alleged $2 billion healthcare fraud in Southern California
3 outlets
4 outlets
Next in today’s stories
Crime & JusticeBreaking
Virginia Sen. L. Louise Lucas indicted on federal drug and money laundering charges
30 outlets
Next in today’s stories
PoliticsDeveloping
Ramaswamy campaign ad featuring Amy Acton’s estranged mother draws backlash
21 outlets
A story one side mostly skipped
PoliticsDeveloping
Rep. Ilhan Omar posts video asking supporters for donations amid federal immigration probe
12 outletsQuiet on the left